Literature DB >> 8321577

Effects of caffeine and diphenhydramine on auditory evoked cortical potentials.

W J Tharion1, J L Kobrick, H R Lieberman, B J Fine.   

Abstract

Caffeine and diphenhydramine are known to affect cognitive functioning in vigilance tasks. In this study, long-latency auditory evoked potentials (AEPs) obtained during concomitant performance of a visual vigilance task were examined for changes in response to administration of caffeine (200 mg) and diphenhydramine (25 mg). The AEPs were also analyzed for changes over time for up to two hours postdrug administration. Significant increases in N1 and P2 latencies and decreases in amplitude voltage were exhibited over time. The P2-N2 amplitude was significantly lower throughout testing after taking caffeine. A significant increase was seen in the P2-N2 amplitude 40 min. after diphenhydramine ingestion. These changes in amplitude may be the result of the auditory stimulus acting as a diversion to the participants while performing the visual vigilance task. Diphenhydramine was more likely to impair participants' vigilance, resulting in greater attention paid toward the auditory stimulus, whereas caffeine seemed to help participants maintain their focus of attention on the visual vigilance task.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321577     DOI: 10.2466/pms.1993.76.3.707

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  3 in total

1.  Acute caffeine effect on repeatedly measured P300.

Authors:  J Pan; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-04       Impact factor: 3.674

2.  Alterations in oropharyngeal sensory evoked potentials (PSEP) with Parkinson's disease.

Authors:  Teresa Pitts; Karen Wheeler Hegland; Christine M Sapienza; Donald C Bolser; Paul W Davenport
Journal:  Respir Physiol Neurobiol       Date:  2016-04-16       Impact factor: 1.931

3.  Effects of caffeine or diphenhydramine on visual vigilance.

Authors:  B J Fine; J L Kobrick; H R Lieberman; B Marlowe; R H Riley; W J Tharion
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.